WHO validates Chad sleeping sickness milestone

The decision was one step in dengue prevention alongside mosquito control and clinical care.

New regional guidance outlined ways to improve management of sickle cell disease.

The documents addressed comprehensive services and coordinated national plans.

Guidance called for strengthening clinical capacity and public understanding.

The publication brought attention to patients and families facing gaps in ongoing care.

Surveillance and access to diagnosis and treatment supported Chad’s achievement.

The WHO validation concerned a specific form of sleeping sickness and a defined public health threshold.

The announcement followed similar WHO validations in other African countries.

A dated report examines discussions during June G20 health meetings in Brazil.

Participants discussed incorporating well-studied practices into health systems.